Home
About
Overview
Sharing Data
ORCID
Help
History (15)
Factor X Deficiency
Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS.
Identification of promiscuous KIF20A long peptides bearing both CD4+ and CD8+ T-cell epitopes: KIF20A-specific CD4+ T-cell immunity in patients with malignant tumor.
Chaney, Diane Burke
Clinical Use of the Urine Biomarker [TIMP-2] × [IGFBP7] for Acute Kidney Injury Risk Assessment.
See All 15 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Clinical Use of the Urine Biomarker [TIMP-2] × [IGFBP7] for Acute Kidney Injury Risk Assessment.
Clinical Use of the Urine Biomarker [TIMP-2] × [IGFBP7] for Acute Kidney Injury Risk Assessment. Am J Kidney Dis. 2016 07; 68(1):19-28.
View in:
PubMed
subject areas
Acute Kidney Injury
Biomarkers
Clinical Trials as Topic
Decision Trees
Early Diagnosis
Humans
Insulin-Like Growth Factor Binding Proteins
Risk Assessment
Tissue Inhibitor of Metalloproteinase-2
authors with profiles
Jay Koyner